Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab
A completed clinical trial evaluating Psoriatic Arthritis patients starting ustekinumab and comparing profiles based on whether care was pro…
-
CLINICAL_TRIALS research · 2025-01-31Clinical Trial Update: Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
A real-world study of Xeligekimab for moderate to severe plaque psoriasis is planned and not yet recruiting, sponsored by Chongqing Genrix B…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
A pregnancy exposure registry studying safety of ustekinumab (Stelara) and guselkumab (Tremfya) during pregnancy in autoimmune diseases; the…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Apremilast Pregnancy Exposure Registry
This is a pregnancy exposure registry for apremilast. The study is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: OTIS Cimzia Pregnancy Registry
This clinical trial registry update describes the OTIS Cimzia Pregnancy Registry sponsored by UC San Diego. It tracks pregnancy outcomes for…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: PsoBest - The German Psoriasis Registry
PsoBest, the German psoriasis registry, is currently recruiting participants to collect data on psoriasis and psoriatic arthritis outcomes. …
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Information
A study is being developed to build a diagnostic model for psoriasis and psoriatic arthritis based on multidimensional nail information; the…
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic Arthritis
The document reports the completion of a multicenter observational study evaluating treat-to-target outcomes in psoriatic arthritis.
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
This document provides a clinical trial update for the MAJIK observational study evaluating outcomes in patients with inflammatory rheumatic…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: BIOTIPRA: BIOmarker-guided Treatment Decisions in Psoriatic and Rheumatoid Arthritis [NA]
Status update for the BIOTIPRA biomarker-guided treatment trial in rheumatoid and psoriatic arthritis. The study is currently active but not…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Diet Interventions in Psoriatic Arthritis [NA]
A completed clinical trial conducted by the University of Pennsylvania evaluated diet interventions for psoriatic arthritis.
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis
This is an observational study update evaluating changes in disease activity and treatment patterns when upadacitinib is given alone or with…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases [Phase 4]
Phase 4 clinical trial is currently enrolling by invitation to evaluate herpes zoster vaccination in patients with inflammatory rheumatic di…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Registry study evaluating patient-reported outcomes, dosing patterns, and safety of Vunakizumab in several rheumatic diseases; recruitment h…
-
EMA withdrawal · 2025-01-06EMA Application withdrawn: Apremilast Viatris (apremilast) — Viatris Limited
The European Medicines Agency has withdrawn Viatris Limited's application for apremilast (Viatris) for the EU market, terminating the market…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA) [Phase 2]
A Phase 2 trial comparing VTX958 to placebo for active Psoriatic arthritis was terminated.
-
FDA approval · 2024-12-26FDA Approved: WEZLANA — Supplemental Application (Nuvaila Limited)
The FDA approved a supplemental Biologics License Application for WEZLANA (ustekinumab-auub) submitted by Nuvaila Limited.
-
FDA approval · 2024-12-20FDA Approved: USTEKINUMAB-TTWE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for USTEKINUMAB-TTWE from Quallent Pharmaceuticals Health LLC. This action confirms additional regul…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
A prospective study to classify psoriatic arthritis and assess disease activity using Power Doppler ultrasonography (PDUS) with recruitment …
-
FDA approval · 2024-12-18FDA Approved: IDACIO — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for IDACIO (adalimumab-aacf) from Fresenius Kabi USA, LLC.
-
FDA approval · 2024-12-17FDA Approved: LEFLUNOMIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Leflunomide from Lupin Pharmaceuticals, Inc., indicating FDA approval of changes to this gen…
-
FDA approval · 2024-12-17FDA Approved: STEQEYMA — Original Application (CELLTRION USA, Inc.)
FDA approved STEQEYMA (ustekinumab-stba) from Celltrion USA as a biosimilar to ustekinumab under an original biologics license application. …
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis [Phase 2]
An update on a Phase 2 trial evaluating the effectiveness and safety of SHR-1314 in psoriatic arthritis. The study is reported as completed.
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Rheumatology Diet Study
A rheumatology dietary intervention study sponsored by the University of Central Florida is currently recruiting, listing multiple autoimmun…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: The Study of Koebner in Patients With Psoriasis and Psoriatic Arthritis
A clinical trial update announcing the completion of a study evaluating the Koebner phenomenon in patients with psoriasis and psoriatic arth…